RENT ADJUSTMENT PERCENTAGE: 2.5% TENANT'S SHARE: 55.85%Lease Agreement • March 10th, 2004 • Biogen Inc • Biological products, (no disgnostic substances)
1 EXHIBIT 4.1 BIOGEN, INC. ANDRights Agreement • April 27th, 1999 • Biogen Inc • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT 10.50 EMPLOYMENT AGREEMENT THIS AGREEMENT by and between Biogen, Inc., a Massachusetts corporation (the "Company"), and James C. Mullen (the "Executive"), dated and effective as of March 6, 2003 (the "Effective Date"). WHEREAS, the Company...Employment Agreement • March 14th, 2003 • Biogen Inc • Biological products, (no disgnostic substances) • Massachusetts
November 21, 1996 Mr. James L. Vincent 7 Audubon Road Weston, MA 02193 Dear Jim: You and Biogen, Inc., as successor by merger to Biogen Research Corp., ("Biogen" or the "Company") are parties to an Employment Agreement dated September 23, 1985 (the...Biogen Inc • March 28th, 1997 • Biological products, (no disgnostic substances)
1 Exhibit 10.24 ------------- FOURTH AMENDMENT TO LEASE FOURTH AMENDMENT TO LEASE dated as of the 6th day of October, 1993 by and between Mortimer B. Zuckerman, Edward H. Linde and David Barrett, Trustees of Fourteen Cambridge Center Trust under...Biogen Inc • March 9th, 1998 • Biological products, (no disgnostic substances)
Exhibit 10.15 ------------- STOCK OPTION AGREEMENT This Agreement is dated as of this 12th day of December, 1997 between Biogen, Inc., a Massachusetts corporation (the "Company"), having its principal office in Cambridge, Massachusetts, and James L....Stock Option Agreement • March 9th, 1998 • Biogen Inc • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT 10.25 FIFTH AMENDMENT TO LEASE FIFTH AMENDMENT TO LEASE (the "Fifth Amendment") dated as of the 9th day of October, 1997 by and between Mortimer B. Zuckerman, Edward H. Linde and David Barrett, Trustees of Fourteen Cambridge Center Trust under...Biogen Inc • March 9th, 1998 • Biological products, (no disgnostic substances)
WITNESSETH:Biogen Inc • June 4th, 1999 • Biological products, (no disgnostic substances)
RECITALSSecond Amendment • March 10th, 2004 • Biogen Inc • Biological products, (no disgnostic substances)
BIOGEN, INC. 14 Cambridge Center Cambridge, MA 02142Biogen Inc • October 18th, 2002 • Biological products, (no disgnostic substances) • Massachusetts
Lease AmendmentLease Amendment • March 10th, 2004 • Biogen Inc • Biological products, (no disgnostic substances)
EXHIBIT 4.1 SECOND AGREEMENT AND AMENDMENT TO RIGHTS AGREEMENT This SECOND AGREEMENT AND AMENDMENT TO RIGHTS AGREEMENT (this "Amendment") is being entered into as of June 20, 2003, between Biogen, Inc., a Massachusetts corporation (the "Company"), and...Second Agreement • June 23rd, 2003 • Biogen Inc • Biological products, (no disgnostic substances) • Massachusetts
Biogen, Inc. has omitted from this Exhibit 10.1.1 portions of the Agreement for which Biogen, Inc. has requested confidential treatment from the Securities and Exchange Commission. The portions of the Agreement for which confidential treatment has...Agreement and Amendment • August 13th, 1998 • Biogen Inc • Biological products, (no disgnostic substances)
BIOGEN, INC. 14 Cambridge Center Cambridge, MA 02142Biogen Inc • October 18th, 2002 • Biological products, (no disgnostic substances)
TRUST AGREEMENT Between BIOGEN, INC. AndTrust Agreement • December 22nd, 1997 • Biogen Inc • Biological products, (no disgnostic substances) • Massachusetts
ANTEGRENDevelopment and Marketing Collaboration Agreement • March 14th, 2003 • Biogen Inc • Biological products, (no disgnostic substances) • New York
April 14, 1995 Dr. Alexander Bearn Professor Emeritus of Medicine Cornell Medical College The Rockefeller University 1230 York Avenue New York, NY 10021-6399 Re: Renewal of Consultancy Agreement Dear Dr. Bearn: Your Consultancy Agreement with Biogen,...Biogen Inc • February 2nd, 1996 • Biological products, (no disgnostic substances)
December 11, 1998 Phillip A. Sharp, Ph.D. Salvador E. Luria Professor Department of Biology Center for Cancer Research Room E17-529B Massachusetts Institute of Technology 40 Ames Street Cambridge, MA 02139-4307 Re: RENEWAL OF INDEPENDENT CONSULTING...Biogen Inc • March 24th, 1999 • Biological products, (no disgnostic substances)
EX-10.38 THIRD AMENDMENT TO LEASE THIS THIRD AMENDMENT TO LEASE ("AMENDMENT") is made and entered into as of OCTOBER 13, 2000, by and between W9/PC LIMITED PARTNERSHIP, a Delaware limited partnership ("LANDLORD") and IDEC PHARMACEUTICALS CORPORATION,...Biogen Inc • March 10th, 2004 • Biological products, (no disgnostic substances)
March 24, 1998 Alexander G. Bearn, M.D. Executive Director American Philosophical Society 104 South 5th St. Philadelphia, PA 19106-3387 Re: RENEWAL OF CONSULTANCY AGREEMENT Dear Alick: Your Consultancy Agreement with Biogen, Inc., dated April 1, 1991...Biogen Inc • March 24th, 1999 • Biological products, (no disgnostic substances)
EXTENSION AGREEMENT This Extension Agreement dated as of December 31, 1995, is between Biogen, Inc., a Massachusetts corporation ("Biogen"), and Biogen Medical Products Limited Partnership, a Massachusetts limited partnership (the "Partnership")....Extension Agreement • February 2nd, 1996 • Biogen Inc • Biological products, (no disgnostic substances)
March 10, 2000Biogen Inc • March 30th, 2001 • Biological products, (no disgnostic substances)
September 23, 1995 Sir Kenneth Murray 4 Mortonhall Road Edinburgh EH9 2HW Scotland, United Kingdom Re: Renewal of Independent Consulting and Project Agreement Dear Ken: Your Independent Consulting and Project Agreement with Biogen, Inc., dated June...Biogen Inc • February 2nd, 1996 • Biological products, (no disgnostic substances)
September 11, 1998 Sir Kenneth Murray 4 Mortonhall Road Edinburgh EH9 2HW Scotland, United Kingdom Re: RENEWAL OF INDEPENDENT CONSULTING AND PROJECT AGREEMENT Dear Ken: Your Independent Consulting and Project Agreement with Biogen, Inc., dated June...Biogen Inc • March 24th, 1999 • Biological products, (no disgnostic substances)
EXHIBIT 10.2 AGREEMENT AND AMENDMENT TO RIGHTS AGREEMENT 1. GENERAL BACKGROUND. In accordance with Section 21 of the Rights Agreement (the "Agreement") between STATE STREET BANK AND TRUST COMPANY ( "State Street Bank") and BIOGEN, INC. ("Biogen")...Rights Agreement • August 14th, 2002 • Biogen Inc • Biological products, (no disgnostic substances)
March 10, 2000 Mr. James L. Vincent 7 Audubon Road Weston, MA 02193 Dear Jim: This letter will serve as notice that Biogen, Inc. would like to extend your chairmanship of the Board of Directors under the terms of the letter agreement dated November...Biogen Inc • March 29th, 2000 • Biological products, (no disgnostic substances)
AGREEMENT AND PLAN OF MERGER BY AND AMONG IDEC PHARMACEUTICALS CORPORATION, BRIDGES MERGER CORPORATION AND BIOGEN, INC. DATED AS OF JUNE 20, 2003Agreement and Plan of Merger • June 23rd, 2003 • Biogen Inc • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of June 20, 2003, by and among IDEC PHARMACEUTICALS CORPORATION, a Delaware corporation (“IDEC”), BRIDGES MERGER CORPORATION, a Massachusetts corporation and a direct wholly owned subsidiary of IDEC (“Merger Sub”), and BIOGEN, INC., a Massachusetts corporation (“Biogen”).
December 15, 1995 Phillip A. Sharp, Ph.D. Salvador E. Luria Professor Department of Biology Center for Cancer Research Room E17-529B Massachusetts Institute of Technology 40 Ames Street Cambridge, MA 02139-4307 Re: Renewal of Independent Consulting...Biogen Inc • February 2nd, 1996 • Biological products, (no disgnostic substances)
STOCK OPTION AGREEMENT This Agreement is dated as of this 22nd day of September, 1995 between Biogen, Inc., a Massachusetts corporation (the "Company"), having its principal office in Cambridge, Massachusetts, and James L. Vincent, an employee and...Stock Option Agreement • February 2nd, 1996 • Biogen Inc • Biological products, (no disgnostic substances) • Massachusetts
